Actually, Big Pharma will be more than interested in this once it works In Vivo.
And given it's use of CAR, there is no reason to think there will be any issues.
Furthermore, the RNA factor means that the exosomes can 'target' specific cancers.....like brain cancers for instance.
This is something the current use of liposomes can not do.
The future of IIQ now it's branching into therapeutics is much much bigger.
I won't be surprised to hear of 'tie ups' soon....especially with the Promega network at their disposal.
Ann: Breakthrough Exosome Therapy, page-46
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
55.5¢ |
Change
0.005(0.91%) |
Mkt cap ! $61.89M | |||
| Open | High | Low | Value | Volume |
| 55.0¢ | 55.5¢ | 55.0¢ | $59.16K | 106.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16449 | 55.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.0¢ | 15000 | 1 |
View Market Depth
| Last trade - 15.42pm 09/09/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |